HomeCompareAVEFF vs GBDC

AVEFF vs GBDC: Dividend Comparison 2026

AVEFF yields 44444.44% · GBDC yields 11.86%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 AVEFF wins by $1.4802188700273396e+23M in total portfolio value
10 years
AVEFF
AVEFF
● Live price
44444.44%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1.4802188700273396e+23M
Annual income
$147,369,615,738,581,320,000,000,000,000.00
Full AVEFF calculator →
GBDC
GBDC
● Live price
11.86%
Share price
$12.65
Annual div
$1.50
5Y div CAGR
51.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.85M
Annual income
$16,450,733.83
Full GBDC calculator →

Portfolio growth — AVEFF vs GBDC

📍 AVEFF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodAVEFFGBDC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, AVEFF + GBDC cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
AVEFF pays
GBDC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

AVEFF
Annual income on $10K today (after 15% tax)
$3,777,777.78/yr
After 10yr DRIP, annual income (after tax)
$125,264,173,377,794,110,000,000,000,000.00/yr
GBDC
Annual income on $10K today (after 15% tax)
$1,007.91/yr
After 10yr DRIP, annual income (after tax)
$13,983,123.76/yr
At 15% tax rate, AVEFF beats the other by $125,264,173,377,794,110,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of AVEFF + GBDC for your $10,000?

AVEFF: 50%GBDC: 50%
100% GBDC50/50100% AVEFF
Portfolio after 10yr
$7.401094350136698e+22M
Annual income
$73,684,807,869,290,660,000,000,000,000.00/yr
Blended yield
99.56%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on GBDC right now

AVEFF
No analyst data
Altman Z
-49.2
Piotroski
4/9
GBDC
Analyst Ratings
6
Buy
5
Hold
Consensus: Buy
Price Target
$14.00
+10.7% upside vs current
Range: $13.00 — $15.00
Altman Z
0.6
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

AVEFF buys
0
GBDC buys
0
No recent congressional trades found for AVEFF or GBDC in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricAVEFFGBDC
Forward yield44444.44%11.86%
Annual dividend / share$2.00$1.50
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%51.1%
Portfolio after 10y$1.4802188700273396e+23M$20.85M
Annual income after 10y$147,369,615,738,581,320,000,000,000,000.00$16,450,733.83
Total dividends collected$1.4797905017086652e+23M$20.43M
Payment frequencyquarterlyquarterly
SectorStockBDC

Year-by-year: AVEFF vs GBDC ($10,000, DRIP)

YearAVEFF PortfolioAVEFF Income/yrGBDC PortfolioGBDC Income/yrGap
1← crossover$4,455,144$4,444,444.44$12,492$1,791.70+$4.44MAVEFF
2$1,855,294,292$1,850,527,287.41$16,527$3,160.58+$1855.28MAVEFF
3$722,201,114,647$720,215,949,754.98$23,588$5,904.90+$722201.09MAVEFF
4$262,786,638,114,837$262,013,882,922,164.10$37,141$11,901.65+$262786638.08MAVEFF
5$89,382,811,928,504,960$89,101,630,225,722,080.00$66,205$26,463.38+$89382811928.44MAVEFF
6$28,419,510,536,946,614,000$28,323,870,928,183,110,000.00$137,452$66,612.65+$28419510536946.48MAVEFF
7$8,446,906,587,814,894,000,000$8,416,497,711,540,360,000,000.00$342,372$195,298.53+$8446906587814894.00MAVEFF
8$2,346,953,255,508,951,600,000,000$2,337,915,065,459,989,300,000,000.00$1,053,292$686,954.33+$2346953255508951552.00MAVEFF
9$609,599,312,292,179,560,000,000,000$607,088,072,308,785,000,000,000,000.00$4,111,439$2,984,416.95+$609599312292179607552.00MAVEFF
10$148,021,887,002,733,950,000,000,000,000$147,369,615,738,581,320,000,000,000,000.00$20,849,974$16,450,733.83+$1.4802188700273396e+23MAVEFF

AVEFF vs GBDC: Complete Analysis 2026

AVEFFStock

Avecho Biotechnology Limited, a biotechnology company, develops, produces, and sells products using its patented platform technology, Targeted Penetration Matrix (TPM) drug delivery system for the pharmaceutical, skin care, animal health, and nutrition industries. It offers TPM and Vital ET products for use in drug delivery and cosmetic formulations; and develops TPM/Oxymorphone and TPM/Oxycodone. The company's human health portfolio covers delivery of pharmaceutical products through gels, injectables, and patches. It also provides non-antibiotic feed additive products to enhance feed efficiency and the health of livestock animals. The company has a collaboration with Lambert Initiative at the University of Sydney to conduct a study to examine whether topically applied cannabidiol can provide relief from symptoms of osteoarthritis. It serves customers in Australia, Switzerland, India, and internationally. The company was formerly known as Phosphagenics Limited and changed its name to Avecho Biotechnology Limited in May 2019. Avecho Biotechnology Limited was incorporated in 1992 and is based in Clayton, Australia.

Full AVEFF Calculator →

GBDCBDC

Golub Capital BDC, Inc. (GBDC) is a business development company and operates as an externally managed closed-end non-diversified management investment company. It invests in debt and minority equity investments in middle-market companies that are, in most cases, sponsored by private equity investors. It typically invests in diversified consumer services, automobiles, healthcare technology, insurance, health care equipment and supplies, hotels, restaurants and leisure, healthcare providers and services, IT services and specialty retails. It seeks to invest in the United States. It primarily invests in first lien traditional senior debt, first lien one stop, junior debt and equity, senior secured, one stop, unitranche, second lien, subordinated and mezzanine loans of middle-market companies, and warrants.

Full GBDC Calculator →
📬

Get this AVEFF vs GBDC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

AVEFF vs SCHDAVEFF vs JEPIAVEFF vs OAVEFF vs KOAVEFF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.